Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Indivior (INDV)

Indivior Prices $500 Million Convertible Notes Due 2031, Repays Note Purchase Agreement

Neutral Impact 3 of 5 financing Written later

Indivior Pharmaceuticals, Inc. issued $500 million of 0.625% convertible senior notes due March 15, 2031, including a $50 million option exercised in full, and used part of the proceeds to prepay and terminate its Note Purchase Agreement dated November 4, 2024. The filing names Indivior Pharmaceuticals, Inc. and ticker INDV, not Supernus, as the request stated; the details here follow the filing. Shareholders face potential dilution of up to 16,202,200 shares on conversion, and the notes add $500 million of senior unsecured debt.

Key points

  • $500 million principal of 0.625% Convertible Senior Notes due March 15, 2031, issued March 17, 2026
  • Initial conversion price of approximately $41.66 per share, a 35.0% premium over the March 12, 2026 closing price
  • Up to 16,202,200 common shares may be issued on conversion at the initial maximum conversion rate
  • Prepaid all outstanding principal, interest and fees under the Note Purchase Agreement; it terminated March 17, 2026

The filing

CompanyIndivior (INDV)
Form8-K, current report
Filed with the SECMar 17, 2026, 4:05 PM ET
Accession number0001625297-26-000015

Items reported: 1.01 Material Definitive Agreement1.02 Termination of Material Agreement2.03 New Direct Financial Obligation3.02 Unregistered Equity Sale

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:07 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.